Neuro-Oncology Biomarkers
Treatment of mind tumors is progressively educated by biomarkers. One use is to properly bunch tumors with comparative hereditary/genomic attributes and to plan preliminaries independently for the individual gatherings. The biomarker's utilization is to foresee patient reaction so the best treatment can be chosen for patients dependent on their tumor attributes. Preliminary plans that select unselected patients are inadequately appropriate for distinguishing medicines successful just in subsets of patients given the generally little quantities of patients accessible for preliminaries.
Related Conference of Neuro-Oncology Biomarkers
June 22-23, 2026
18th Global Neurologists Meeting on Neurology and Neurosurgery
Amsterdam, Netherlands
June 29-30, 2026
31st International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences
Paris, France
July 20-21, 2026
11th International Conference on Central Nervous System Disorders & Therapeutics
Amsterdam, Netherlands
July 23-24, 2026
14th International Conference on Cannabis & Medicinal Research
Amsterdam, Netherlands
September 17-18, 2026
31st Global Experts Meeting on Neuroscience and Neuropharmacology
Paris, France
April 27-28, 2027
18th International Conference on Stroke, Neurology and Cerebrovascular Diseases
Paris, France